In the setting of cancer, several studies have found enhanced numbers of tumor-specific polyfunctional T cells in patients responding favorably to various forms of immunotherapy, including adoptive T-cell therapy, α-CTLA-4 antibody therapy, and tumor vaccines [32], [33], [34], [35], [36]. Here, CTLA4 is linked to neoplasm.